WikiPatents - Community Patent Review
Create Free Account  |  License or Sell Your Patent  |  WikiPatents Marketplace  |  WikiPatents Blog
Username:  Password:  
    
Advanced Search
Minimum procedure system for the determination of analytes    

Custom CD of patents similar to US4935346 : Minimum procedure system for the determination of analytes - $19.95
United States Patent4935346   
Link to this pagehttp://www.wikipatents.com/4935346.html
Inventor(s)Phillips; Roger (Palo Alto, CA); McGarraugh; Geoffery (Scotts Valley, CA); Jurik; Frank (San Mateo, CA); Underwood; Ray (Red Bluff, CA)
AbstractA method for determining the presence of an analyte in a fluid is described along with various components of an apparatus specifically designed to carry out the method. The method involves taking a reflectance reading from one surface of an inert porous matrix impregnated with a reagent that will interact with the analyte to produce a light-absorbing reaction product when the fluid being analyzed is applied to another surface and migrates through the matrix to the surface being read. Reflectance measurements are made at two separate wavelengths in order to eliminate interferences, and a timing circuit is triggered by an initial decrease in reflectance by the wetting of the surface whose reflectance is being measured by the fluid which passes through the inert matrix. The method and apparatus are particularly suitable for the measurement of glucose levels in blood without requiring separation of red blood cells from serum or plasma.
   














 Title Information Submit all comments and votes
 
Patent Text Patent PDF Print Page Summary File History
Plain text PDF images Print Summary File History
Inventor     Phillips; Roger (Palo Alto, CA); McGarraugh; Geoffery (Scotts Valley, CA); Jurik; Frank (San Mateo, CA); Underwood; Ray (Red Bluff, CA)
Owner/Assignee     Lifescan, Inc. (Mountain View, CA)
Patent assignment
All assignments
Company News
Publication Date     June 19, 1990
Application Number     06/896,418
PAIR File History     Application Data   Transaction History
Image File Wrapper   Patent Term   Fees
Litigation
Filing Date     August 13, 1986
US Classification     435/14 422/56 422/57 422/58 422/61 422/68.1 435/4 435/25 435/28 435/805 435/808 435/810 436/24 436/46 436/63 436/95 436/166 436/169
Int'l Classification     C12Q 001/54 C12Q 001/32
Examiner     Kepplinger; Esther M.
Assistant Examiner     Spiegel; Carol A.
Attorney/Law Firm     Neeley; Richard L.
Address
Parent Case    
Priority Data    
USPTO Field of Search     435/4 435/14 435/25 435/28 435/805 435/808 435/810 436/24 436/46 436/63 436/95 436/166 436/169 422/56 422/57 422/58 422/61 422/68
Patent Tags     minimum procedure determination analytes
   
Enter a comma (,) or semicolon (;) between multiple tag words/phrases.
Describe this patent:
 Amusing   
 Clever   
 Complex   
 Efficient   
 Historic   
 Important   
 Innovative   
 Interesting   
 Practical   
 Simple   
[no votes]
Patent WIKI

Share information and news about this patent, including information and news about the technology, inventors, company, ligation and licensing.

 References Submit all comments and votes
 
*references marked with an asterisk below are user-added references
 U.S. References
 
Add a new US reference:  
ReferenceRelevancyCommentsReferenceRelevancyComments
2893843



[0 after 0 votes]
2893844



[0 after 0 votes]
3061523



[0 after 0 votes]
3092465



[0 after 0 votes]
3099605



[0 after 0 votes]
3127281



[0 after 0 votes]
3298789



[0 after 0 votes]
3443903



[0 after 0 votes]
3506126



[0 after 0 votes]
3552928



[0 after 0 votes]
3591480



[0 after 0 votes]
3607093



[0 after 0 votes]
3630957



[0 after 0 votes]
3650698



[0 after 0 votes]
3672838



[0 after 0 votes]
3718439



[0 after 0 votes]
3785772



[0 after 0 votes]
4509859
Markart
356/446
Apr,1985

[0 after 0 votes]
4476222
Ohtani
435/14
Oct,1984

[0 after 0 votes]
4427632
Okaniwa
422/56
Jan,1984

[0 after 0 votes]
4420566
Jessop
436/46
Dec,1983

[0 after 0 votes]
4340669
Bauer
435/14
Jul,1982

[0 after 0 votes]
4297238
Vormbrock
436/17
Oct,1981

[0 after 0 votes]
4288228
Oberhardt
436/178
Sep,1981

[0 after 0 votes]
4258001
Pierce
422/56
Mar,1981

[0 after 0 votes]
4238196
Acuff
436/67
Dec,1980

[0 after 0 votes]
4211845
Genshaw
435/14
Jul,1980

[0 after 0 votes]
4178153
Sodickson
436/165
Dec,1979

[0 after 0 votes]
4057394
Genshaw
435/66
Nov,1977

[0 after 0 votes]
4056468
Breiter
210/672
Nov,1977

[0 after 0 votes]
3990849
Lee
436/169
Nov,1976

[0 after 0 votes]
3979274
Newman
204/403.09
Sep,1976

[0 after 0 votes]
3958560
March
600/319
May,1976

[0 after 0 votes]
3811840
Bauer
422/56
May,1974

[0 after 0 votes]
3703336
Rosse
356/39
Nov,1972

[0 after 0 votes]
3660638
Oberli
422/66
May,1972

[0 after 0 votes]
4710458
Maines
435/12
Dec,1969

[0 after 0 votes]
 Foreign References
 Other References
 Market Review Submit all comments and votes
   
Market Size
Estimate the gross annual revenues of the relevant market sector:
> $10B
$5B - $10B
$2B - $5B
$500M - $2B
$100M - $500M
$10M - $100M
$1M - $10M
$500K - $1M
$100K - $500K
< $100K
[No votes]
$0
 
$0   $2.5B   $5B   $7.5B   $10B

[0 market size comments]
Market Share
Estimate the percentage of the relevant market sector this invention will capture:
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 market share comments]
Reasonable Royalty
What percentage of gross sales should the inventor or assignee be paid?
75% - 100%
50% - 74.99%
25% - 49.99%
10 - 24.99%
5 - 9.99%
2 - 4.99%
1 - 1.99%
< 1%
[No votes]
0.0%
 
0%   25%   50%   75%   100%

[0 reasonable royalty comments]
Public's "Guesstimation" of Royalty Value
Market SizeN/A[No votes]
xMarket ShareN/A[No votes]
xReasonable RoyaltyN/A[No votes]

N/A

[0 Guesstimation of Royalty Value Comments]
License Availablity
If you are NOT the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 license availability comments]
License Availablity
If you ARE the owner or assignee, answer here:
Yes, license is available for purchase

No, license is not currently available



[No votes]
[0 owner/assignee comments]
Competitive Advantage
Does this invention have a significant competitive advantage over similar technologies?
Yes

No



[No votes]
Most helpful competitive advantage comment
[No comments]

[0 competitive advantage comments]
Commercial Alternatives
Are there viable commercial alternatives for this invention?
Yes

No



[No votes]
Most helpful commercial alternative comment
[No comments]

[0 commercial alternatives comments]
 Technical Review Submit all comments and votes
 Claims Submit all comments and votes
 


What is claimed is:

1. In a method for determining glucose in a blood sample employing a membrane and a signal-producing system which reacts with glucose to produce a light-absorptive dye product, said system being bound to the membrane, and in which the amount of said dye product is determined by means of a reflectance measurement from a surface of said membrane, an improvement which comprises:

applying an unmeasured whole blood sample to a first surface of a single-layer, substantially reflective, porous, hydrophilic membrane having pores of a size sufficient to exclude red blood cells and which contains said signal-producing system;

making said reflectance measurement on a second surface of said membrane other than the surface to which said sample is applied without removing excess sample or red blood cells from said first surface; and

determining the concentration of glucose in said sample from said reflectance measurement.

2. A method according to claim 1, wherein said signal-producing system produces a dye product which absorbs light at a wavelength different from a wavelength at which said red blood cells absorb and said reflectance measurement is made at two different wavelengths, one absorption wavelength reflectance measurement to correct for background absorbance due to red blood cells and the other reflectance measurement at the absorption wavelength of said dye product.

3. A method according to claim 2, wherein said two wavelengths are at about 635 and 700 nm.

4. A method according to claim 1, wherein said signal producing system comprises glucose oxidase, peroxidase, 3-methyl-2-benzothiazolinone hydrazone/3-(dimethylamino)benzoic acid in a weight ratio of about 1:1 to about 4:1 as an indicator, and a buffer providing a pH of 3.8 to 5.0.

5. The method of claim 4, wherein said buffer comprises 5-15 weight % citrate buffer dried in said membrane.

6. A method according to claim 1 wherein said membrane comprises polyamide and said signal producing system comprises glucose oxidase, peroxidase, and 3-methyl-2-benzothiazolinone hydrazone/3-(dimethylamino)benzoic acid.

7. The method of claim 1, wherein said pores have an average diameter of from about 0.1 to about 3.0 .mu.m.

8. The method of claim 1, wherein said membrane consists essentially of polyamide and has a thickness of from about 0.01 to about 0.5 mm.

9. The method of claim 1, wherein said membrane consists essentially of polyamide and has a pore volume of less than 10 .mu.l in said second surface.

10. A method for determining glucose comprising the sequential steps of:

(a) applying a whole blood sample to an application site on a reagent element wherein said reagent element comprises a single-layer, substantially reflective, porous, hydrophilic matrix which filters out red blood cells and to which is bound a signal-producing system comprising glucose oxidase, peroxidase and a dye indicator, which signal-producing system reacts with glucose to form a reaction dye product;

(b) allowing the sample to migrate to a reading site on said membrane different from said application site;

(c) monitoring reflectance at said reading site for a decrease in reflectance indicative of sample presence in said reading site in order to initiate timing of an incubation period;

and

(d) determining the change in reflectance at said reading site during the incubation period as a measure of dye product formed to determine the amount of glucose in said sample

wherein

all reflectance measurements at said reading site are performed without removing excess sample or red blood cells from said application site and at least one measurement is taken at a wavelength at which light is absorbed by said dye product.

11. A method according to claim 10, wherein said dye indicator is 3-methyl-2-benzothiazolinonehydrazone/3-(dimethylamino)benzoic acid.

12. A method according to claim 10, wherein said hydrophilic membrane comprises a polyamide.

13. A method according to claim 12, wherein said hydrophilic membrane is positively charged.

14. The method of claim 10, wherein said determination of the amount of glucose in said sample further includes determining the change in reflectance at a second wavelength to provide a correction for background absorbance at the dye product absorbing wavelength due to an interfering substance in said sample.

15. A method of determining analyte concentration in a liquid, which comprises:

quantitatively measuring baseline reflectance from a first surface of a reagent element comprising an inert, porous, hydrophilic, substantially reflective, single-layer matrix having pores of a size sufficient to exclude red blood cells and a reagent system which interacts with said analyte to produce a light-absorbing reaction product, said reagent system being impregnated in the pores of said matrix, prior to application of said liquid to said reagent element;

applying said liquid to a second surface of said reagent element and allowing said liquid to migrate from said second surface to said first surface;

quantitatively measuring reaction reflectance from said first surface of said reagent element without removing excess sample or non-migrating components of said sample from said second surface;

quantitatively measuring reflectance of interfering substances from said first surface of said reagent element using a wavelength of light reflected by interfering substances and different from the wavelength of light used to measure said reaction product reflectance in order to correct for background reflectance at the reaction product wavelength caused by interfering substances; and

calculating a value expressing said analyte concentration from said reflectance measurements.

16. The method of claim 15, wherein said matrix comprises a polyamide.

17. The method of claim 15, wherein the average diameter of the pores in said matrix is from 0.2 to 1.0 .mu.m and said liquid is whole blood.

18. The method of claim 17, wherein said analyte is glucose, and said reagent produces a light-absorbing reaction product upon reacting with glucose.
 Description Submit all comments and votes
 


FIELD OF THE INVENTION

The present invention relates to a test device and method for the colorimetric determination of chemical and biochemical components (analytes) in aqueous fluids, particularly whole blood. In one preferred embodiment it concerns a test device and method for colorimetrically measuring the concentration of glucose in whole blood.

BACKGROUND OF THE INVENTION

The quantification of chemical and biochemical components in colored aqueous fluids, in particular colored biological fluids such as whole blood and urine and biological fluid derivatives such as serum and plasma, is of ever-increasing importance. Important applications exist in medical diagnosis and treatment and in the quantification of exposure to therapeutic drugs, intoxicants, hazardous chemicals and the like. In some instances, the amounts of materials being determined are either so miniscule--in the range of a microgram or less per deciliter--or so difficult to precisely determine that the apparatus employed is complicated and useful only to skilled laboratory personnel. In this case the results are generally not available for some hours or days after sampling. In other instances, there is often an emphasis on the ability of lay operators to perform the test routinely, quickly and reproducibly outside a laboratory setting with rapid or immediate information display.

One common medical test is the measurement of blood glucose levels by diabetics. Current teaching counsels diabetic patients to measure their blood glucose level from two to seven times a day depending on the nature and severity of their individual cases. Based on the observed pattern in the measured glucose levels the patient and physician together make adjustments in diet, exercise and insulin intake to better manage the disease. Clearly, this information should be available to the patient immediately.

Currently a method widely used in the United States employs a test article of the type described in U.S. Pat. No. 3,298,789 issued Jan. 17, 1967 to Mast. In this method a sample of fresh, whole blood (typically 20-40 .mu.l) is placed on an ethylcellulose-coated reagent pad containing an enzyme system having glucose oxidase and peroxidase activity. The enzyme system reacts with glucose and releases hydrogen peroxide. The pad also contains an indicator which reacts with the hydrogen peroxide in the presence of peroxidase to give a color proportional in intensity to the sample's glucose level.

Another popular blood glucose test method employs similar chemistry but in place of the ethylcellulose-coated pad employs a water-resistant film through which the enzymes and indicator are dispersed. This type of system is disclosed in U.S. Pat. No. 3,630,957 issued Dec. 28, 1971 to Rey et al.

In both cases the sample is allowed to remain in contact with the reagent pad for a specified time (typically one minute). Then in the first case the blood sample is washed off with a stream of water while in the second case it is wiped off the film. The reagent pad or film is then blotted dry and evaluated. The evaluation is made either by comparing color generated with a color chart or by placing the pad or film in a diffuse reflectance instrument to read a color intensity value.

While the above methods have been used in glucose monitoring for years, they do have certain limitations. The sample size required is rather large for a finger stick test and is difficult to achieve for some people whose capillary blood does not express readily.

In addition, these methods share a limitation with other simple lay-operator colorimetric determinations in that their result is based on an absolute color reading which is in turn related to the absolute extent of reaction between the sample and the test reagents. The fact that the sample must be washed or wiped off the rea